Free for Drug Developers
September 26
Immuno-Oncology MicroSummit
Quarter 3: Session 3
A hyper-focused Online Experience in 55 minutes
Novel Immunotherapies and Leading Strategies with rapid insights from Large Pharma and Biotech. Learn about new approaches and discuss the latest challenges with like minded peers from across the industry.
By Neo Synth
123
When and Where
Tue, September 26, 2023
10:00 AM - 10:55 AM PDT
Online in 55 minutes
One Window Technology
Speakers & Facilitators
Presentations and Conversation prompts by:
Jena Giltnane
Research Director, Digital & Spatial Pathology Genentech
Frank Borriello
Founder & CEO
Alloplex Biotherapeutics
Laura Dillon
Vice President Translational Medicine
Parthenon Therapeutics
Priya Ganesan
Scientist, Oncology
Amgen
William Williams
President & CEO
BriaCell Therapeutics
David Feltquate
Chief Medical Officer
Palleon Pharmaceuticals
Michael Surace
Director, TME & IO, Translational Medicine,
AstraZeneca
Niv Chowdhury
Scientist II, Translational Sciences
Atreca, Inc.
Anish Suri
Chief Scientific Officer
Cue Biopharma
Presentations
There are three types of highly curated content:
Pipeline Updates & Insights
Teaser videos about the latest in the pipelines of large drug developers, presented by leading experts.
New Innovations
Biotechnology innovations from the pipelines of small to mid-sized pharma
Conversation Prompts
Strategic Peer to Peer Problem solving prompted by video questions.
How it Works
Prepare for the Micro Summit by watching the 60 second video below:
© 2023 MicroSummits